UNSPSC 51386609: Hydrocortisone/lidocaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE200. This VA Drug Class (DE200) classifies this compound as belonging to the group ANTI-INFLAMMATORY, TOPICAL.

UNSPSC 51386609 Hydrocortisone/lidocaine is a Commodity code, but the recent state and local contract opportunities posted under it show no procurement of hydrocortisone/lidocaine preparations themselves. Instead, the code has drawn solicitations for naloxone, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer prescription program services — none of which align with the topical corticosteroid-anesthetic combination the code nominally covers. The mismatch suggests that state and local procurement offices are either applying this code incorrectly to broader pharmaceutical purchasing, or the code is being used as a catch-all for pharmaceutical inventory and supply-chain management that extends well beyond the specific drug product named.

The three most recent opportunities span different issuing bodies and procurement approaches. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building, with bids due July 26, 2023. The Texas Health and Human Services Commission released RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program — a preliminary market-intelligence exercise rather than a formal competitive bid. The Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring participation through authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) and pricing weighted 75 percent on competitiveness. The code shows activity in the Southeast and Upper Midwest, with involvement of a state health department (Texas), a county health agency (Seminole County), and a multistate cooperative vehicle, but the recent opportunities do not substantiate procurement of hydrocortisone/lidocaine itself and offer limited guidance for vendors seeking to pursue work under this code's nominal scope.